| Quote | Spy HGSI NEW ![]() |
Message Board | |||||
|
Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders. |
|
Placing Bets On Human Genome’s Benlysta
WYE LLY MRK AMGN THOR HGSI GSK Linked by tickerspy blog - November 05, 12:35PM from (www.tickerspy.com) There has been a lot of hype surrounding Human Genome Sciences' (HGSI) lupus drug recently. To those more ...
Closing Bell: The great mixed day (BDK, CHK, CSX, RIMM, NEM, WFC, HGSI)
BDK WFC CSX CHK HGSI RIMM NEM Linked by BloggingStocks - November 03, 04:00PM from (www.bloggingstocks.com) Was today about stocks, or was it about the FOMC starting its 2-day meeting? Or was it about mergers or a huge Indian gold more ...
Closing Bell: late-day greed trumped fear (CIT, RIMM, HGSI, MSFT, ETFC)
MSFT HGSI ETFC RIMM CITGQ Linked by BloggingStocks - November 02, 04:00PM from (www.bloggingstocks.com) Today was a whip-around day. All day. Despite better construction and better manufacturing employment data, the markets looked more ...
Genomics: No Longer A Failure
JNJ VRTX HGSI DNDN GSK Linked by Forbes - November 02, 11:13AM from (www.forbes.com) Mapping the human genome produced far more hype than drugs. That's starting to change. more ...
Top Day Trader Alerts
F MOT HGSI DNDN CITGQ Linked by 24/7 Wall St. - November 02, 08:57AM from (247wallst.com) This is a strange morning for day trader alerts. There are not dozens and dozens of stocks in the big news, but those that more ...
Human Genome Sciences and GlaxoSmithKline Announce Positive Results in Second of Two Phase 3 Trials of BENLYSTA™ in Systemic Lupus Erythematosus
HGSI Linked by BusinessWire - November 02, 07:00AM from (www.businesswire.com) Human Genome Sciences, Inc. (Nasdaq:HGSI) and GlaxoSmithKline PLC (GSK) today announced that BENLYSTA™ (belimumab) more ...
Media Digest 11/2/2009 Reuters, WSJ, NYTimes, FT, Bloomberg
JPM F GE BAC PFE WMT FNM AAPL C GS HGSI DNR EBAY EAC CMCSA CITGQ BK BX Linked by 24/7 Wall St. - November 02, 03:54AM from (247wallst.com) Reuters: Investors in the banking sector were disturbed by the CIT (NYSE:CIT) bankruptcy. Reuters: Summers will lead a high level meeting on the economy. more ...
Lupus Drug Shows Promise in New Trial
HGSI Linked by NYTimes - November 02, 01:48AM from (feeds.nytimes.com) Human Genome Sciences said early Monday that its experimental drug to treat lupus was effective in its second big clinical more ...
Human Genome Sciences and GlaxoSmithKline Announce Positive Results in Second of Two Phase 3 Trials of BENLYSTA™ in Systemic Lupus Erythematosus
HGSI Linked by BusinessWire - November 02, 12:01AM from (www.businesswire.com) Human Genome Sciences, Inc. (Nasdaq:HGSI) and GlaxoSmithKline PLC (GSK) today announced that BENLYSTA™ (belimumab) more ...
The Unusual Suspects (BEAT, CIT, CIT-PZ, GNW, GFIG, HGSI, GSK, MCO, BRK-A, RVSN, CSCO)
CSCO HGSI MCO RVSN BEAT GSK CITGQ GNW GFIG Linked by 24/7 Wall St. - November 01, 10:33AM from (247wallst.com) Earnings season is seeming to wind down here, but that won't stop the unusual suspects of key equity events and issues to more ...
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2009 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF. |
|